Day One Biopharmaceuticals (DAWN) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Q3 2025 value amounting to -$0.19.
- Day One Biopharmaceuticals' EPS (Weighted Average and Diluted) fell 15000.0% to -$0.19 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.52, marking a year-over-year decrease of 4757.28%. This contributed to the annual value of -$2.2 for FY2024, which is 735.5% up from last year.
- Per Day One Biopharmaceuticals' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.19 for Q3 2025, which was down 15000.0% from -$0.29 recorded in Q2 2025.
- In the past 5 years, Day One Biopharmaceuticals' EPS (Weighted Average and Diluted) registered a high of $0.38 during Q3 2024, and its lowest value of -$0.72 during Q1 2024.
- In the last 3 years, Day One Biopharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.44 in 2023 and averaged -$0.37.
- Per our database at Business Quant, Day One Biopharmaceuticals' EPS (Weighted Average and Diluted) surged by 17037.04% in 2024 and then tumbled by 48000.0% in 2025.
- Quarter analysis of 3 years shows Day One Biopharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.64 in 2023, then fell by 10.15% to -$0.7 in 2024, then surged by 73.05% to -$0.19 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.19 for Q3 2025, versus -$0.29 for Q2 2025 and -$0.35 for Q1 2025.